NCT01483001View on ClinicalTrials.gov

Feasibility Study on Stem Cells Sensitivity Assay

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2013

Conditions
Lung CancerColorectal CancerBreast Cancer
Interventions
DRUG

Cancer Stem Cells Sensitivity Assay

To test in vitro sensitivity of cancer stem cells to several antineoplastic drugs in order to personalize treatment

Trial Locations (1)

57100

Department of Medical Oncology, Livorno

All Listed Sponsors
lead

Associazione Oncologia Traslazionale

OTHER

NCT01483001 - Feasibility Study on Stem Cells Sensitivity Assay | Biotech Hunter | Biotech Hunter